Even if an experiment is double-blind, the blinding might be compromised if side effects of the treatments differ. For example, suppose researchers at a skin-care company are comparing their new acne treatment against that of the leading competitor. Fifty subjects are assigned at random to each treatment, and the company’s researchers will rate the improvement for each of the 100 subjects. The researchers aren’t told which subjects received which treatments, but they know that their new acne treatment causes a slight reddening of the skin. How might this knowledge compromise the blinding? Explain why this is an important consideration in the experiment.